Skip to main content

Care

By Jessica Hagen | 12:18 pm | March 24, 2023
The AI-powered app allows for remote monitoring of common Parkinson's disease symptoms such as bradykinesia, tremor and dyskinesia via an Apple Watch.
By Emily Olsen | 12:17 pm | March 24, 2023
In a letter, the senator urged the agency to scrutinize the acquisition and others like it, arguing the deal could increase costs and lower quality of care.
By Emily Olsen | 11:27 am | March 24, 2023
Christopher Lis, managing director of global healthcare intelligence at J.D. Power, discusses the recent primary care deals by Amazon and CVS Health.
By Jessica Hagen | 10:52 am | March 23, 2023
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
By Jessica Hagen | 10:52 am | March 23, 2023
A study published in The New England Journal of Medicine found a closed-loop control system kept children's glucose levels in the target range longer than standard care.
By Adam Ang | 02:44 am | March 23, 2023
It also received backing from the founding members of Grab and Zalora.  
By Emily Olsen | 03:27 pm | March 22, 2023
The acquisition includes Mindstrong's technology assets and some of its employees.
By Emily Olsen | 02:00 pm | March 22, 2023
The program will be available through Amwell in the second half of 2023.
By Adam Ang | 03:43 am | March 22, 2023
It now plans to release more hypnosis-based DTx apps for anxiety, sleep, and chronic pain.
By Emily Olsen | 03:24 pm | March 21, 2023
Maven said the acquisition of Naytal will accelerate its growth in the U.K. and Europe.